News for Wave Life Sciences Ltd. (WVE)

Wave Life Sciences Ltd. shares promising updates on AATD & DMD treatments. Click here for my updated look at WVE stock prospects.

Revenue (Q4 2024): $83.7 million.Revenue (Full Year 2024): $108.3 million.Research and Development Expenses (Q4 2024): $44.6 million.Research and Development E

Wave Life Sciences Ltd. (NASDAQ:WVE) Q4 2024 Earnings Conference Call March 4, 2025 8:30 AM ETCompany ParticipantsKate Rausch - VP, IR & Corporate...

WAVE Life Sciences Ltd (WVE), a clinical-stage biotechnology company, has announced its financial results for the fourth quarter and full year ending December 3

Dosing underway in INLIGHT trial of WVE-007 in obesity with clinical data expected in 2H 2025; enrollment complete in first single dose cohort Multi-dosing ong

**media[556711]**

WAVE Life Sciences Ltd (WVE) is set to release its Q4 2024 earnings on Mar 4, 2025. The consensus estimate for Q4 2024 revenue is $28.04 million, and the earnin

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

WAVE Life Sciences Ltd (WVE), a clinical-stage biotechnology company dedicated to advancing RNA medicines, has announced a live webcast and conference call sche

CAMBRIDGE, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. ( WVE), a clinical-stage biotechnology company focused on unlocking the broad pote

Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2024 investor letter.

On December 31, 2024, Lee Ainslie (Trades, Portfolio), the founder and CEO of Maverick Capital, executed a significant reduction in the holdings of WAVE Life Sc

On December 31, 2024, 683 Capital Management, LLC (Trades, Portfolio) made a significant move by acquiring an additional 721,999 shares of Modular Medical Inc (

On December 31, 2024, 683 Capital Management, LLC (Trades, Portfolio) executed a strategic transaction involving Inspired Entertainment Inc (NASDAQ: INSE). The

On December 31, 2024, 683 Capital Management, LLC (Trades, Portfolio) executed a significant transaction by reducing its holdings in Affimed NV by 270,000 share

We recently published a list of the Top 10 Small Cap Stocks to Buy with the Highest Upside Potential. In this article, we are going to take a look at where Wave Life Sciences Ltd.

We recently compiled a list of the 12 Best Growth Stocks Under $25 to Buy Now. In this article, we are going to take a look at where Wave Life Sciences Ltd.

Wave Life Sciences shows promising data in genetic mutation treatments, with GSK collaborations and strong financial footing. See why WVE stock is a Buy.

Summary WAVE Life Sciences Ltd (WVE), a clinical-stage biotechnology company, has announced the submission of its first clinical trial application (CTA) for WVE